The global Fabry Disease Therapeutic market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fabry Disease Therapeutic in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Fabry Disease Therapeutic market. Enzyme Replacement Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Alternative therapies segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fabry Disease Therapeutic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Fabry Disease Therapeutic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Fabry Disease Therapeutic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fabry Disease Therapeutic sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Fabry Disease Therapeutic covered in this report include Amicus therapeutics, Takeda, Genzyme-Sanofi, Protalix, Sanofi-Aventis LLC, Novartis Pharmaceuticals, Pfizer, Bristol-Myers Squibb Company and GlaxoSmithKline plc, etc.

The global Fabry Disease Therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Amicus therapeutics

Takeda

Genzyme-Sanofi

Protalix

Sanofi-Aventis LLC

Novartis Pharmaceuticals

Pfizer

Bristol-Myers Squibb Company

GlaxoSmithKline plc

Amgen Inc.

Teva pharmaceutical Industries Ltd.

Merc & Co.

AbbVie Inc.

Takeda Pharmaceutical Co. Ltd.

Green Cross Corp.

Scope of Fabry Disease Therapeutic - Market Report

Report Metric	Details
Report Name	Fabry Disease Therapeutic - Market
CAGR	5%
Global Fabry Disease Therapeutic market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fabry Disease Therapeutic market, Segment by Type:	Enzyme Replacement Therapy Alternative therapies
Global Fabry Disease Therapeutic market, by Application	Hospitals Clinics Other
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fabry Disease Therapeutic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the Fabry Disease Therapeutic - Market report?

Ans: The Applications covered in the Fabry Disease Therapeutic - Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Fabry Disease Therapeutic - Market report?

Ans: The Types covered in the Fabry Disease Therapeutic - Market report are Enzyme Replacement Therapy, Alternative therapies

1 Market Overview of Fabry Disease Therapeutic

1.1 Fabry Disease Therapeutic Market Overview

1.1.1 Fabry Disease Therapeutic Product Scope

1.1.2 Fabry Disease Therapeutic Market Status and Outlook

1.2 Global Fabry Disease Therapeutic Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Fabry Disease Therapeutic Market Size by Region (2018-2029)

1.4 Global Fabry Disease Therapeutic Historic Market Size by Region (2018-2023)

1.5 Global Fabry Disease Therapeutic Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Fabry Disease Therapeutic Market Size (2018-2029)

1.6.1 North America Fabry Disease Therapeutic Market Size (2018-2029)

1.6.2 Europe Fabry Disease Therapeutic Market Size (2018-2029)

1.6.3 Asia-Pacific Fabry Disease Therapeutic Market Size (2018-2029)

1.6.4 Latin America Fabry Disease Therapeutic Market Size (2018-2029)

1.6.5 Middle East & Africa Fabry Disease Therapeutic Market Size (2018-2029)

2 Fabry Disease Therapeutic Market by Type

2.1 Introduction

2.1.1 Enzyme Replacement Therapy

2.1.2 Alternative therapies

2.2 Global Fabry Disease Therapeutic Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Fabry Disease Therapeutic Historic Market Size by Type (2018-2023)

2.2.2 Global Fabry Disease Therapeutic Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Fabry Disease Therapeutic Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Fabry Disease Therapeutic Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Fabry Disease Therapeutic Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Fabry Disease Therapeutic Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Fabry Disease Therapeutic Revenue Breakdown by Type (2018-2029)

3 Fabry Disease Therapeutic Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Clinics

3.1.3 Other

3.2 Global Fabry Disease Therapeutic Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Fabry Disease Therapeutic Historic Market Size by Application (2018-2023)

3.2.2 Global Fabry Disease Therapeutic Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Fabry Disease Therapeutic Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Fabry Disease Therapeutic Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Fabry Disease Therapeutic Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Fabry Disease Therapeutic Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Fabry Disease Therapeutic Revenue Breakdown by Application (2018-2029)

4 Fabry Disease Therapeutic Competition Analysis by Players

4.1 Global Fabry Disease Therapeutic Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fabry Disease Therapeutic as of 2022)

4.3 Date of Key Players Enter into Fabry Disease Therapeutic Market

4.4 Global Top Players Fabry Disease Therapeutic Headquarters and Area Served

4.5 Key Players Fabry Disease Therapeutic Product Solution and Service

4.6 Competitive Status

4.6.1 Fabry Disease Therapeutic Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Amicus therapeutics

5.1.1 Amicus therapeutics Profile

5.1.2 Amicus therapeutics Main Business

5.1.3 Amicus therapeutics Fabry Disease Therapeutic Products, Services and Solutions

5.1.4 Amicus therapeutics Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.1.5 Amicus therapeutics Recent Developments

5.2 Takeda

5.2.1 Takeda Profile

5.2.2 Takeda Main Business

5.2.3 Takeda Fabry Disease Therapeutic Products, Services and Solutions

5.2.4 Takeda Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.2.5 Takeda Recent Developments

5.3 Genzyme-Sanofi

5.3.1 Genzyme-Sanofi Profile

5.3.2 Genzyme-Sanofi Main Business

5.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Products, Services and Solutions

5.3.4 Genzyme-Sanofi Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.3.5 Protalix Recent Developments

5.4 Protalix

5.4.1 Protalix Profile

5.4.2 Protalix Main Business

5.4.3 Protalix Fabry Disease Therapeutic Products, Services and Solutions

5.4.4 Protalix Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.4.5 Protalix Recent Developments

5.5 Sanofi-Aventis LLC

5.5.1 Sanofi-Aventis LLC Profile

5.5.2 Sanofi-Aventis LLC Main Business

5.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Products, Services and Solutions

5.5.4 Sanofi-Aventis LLC Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.5.5 Sanofi-Aventis LLC Recent Developments

5.6 Novartis Pharmaceuticals

5.6.1 Novartis Pharmaceuticals Profile

5.6.2 Novartis Pharmaceuticals Main Business

5.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Products, Services and Solutions

5.6.4 Novartis Pharmaceuticals Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.6.5 Novartis Pharmaceuticals Recent Developments

5.7 Pfizer

5.7.1 Pfizer Profile

5.7.2 Pfizer Main Business

5.7.3 Pfizer Fabry Disease Therapeutic Products, Services and Solutions

5.7.4 Pfizer Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.7.5 Pfizer Recent Developments

5.8 Bristol-Myers Squibb Company

5.8.1 Bristol-Myers Squibb Company Profile

5.8.2 Bristol-Myers Squibb Company Main Business

5.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Products, Services and Solutions

5.8.4 Bristol-Myers Squibb Company Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.8.5 Bristol-Myers Squibb Company Recent Developments

5.9 GlaxoSmithKline plc

5.9.1 GlaxoSmithKline plc Profile

5.9.2 GlaxoSmithKline plc Main Business

5.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Products, Services and Solutions

5.9.4 GlaxoSmithKline plc Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.9.5 GlaxoSmithKline plc Recent Developments

5.10 Amgen Inc.

5.10.1 Amgen Inc. Profile

5.10.2 Amgen Inc. Main Business

5.10.3 Amgen Inc. Fabry Disease Therapeutic Products, Services and Solutions

5.10.4 Amgen Inc. Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.10.5 Amgen Inc. Recent Developments

5.11 Teva pharmaceutical Industries Ltd.

5.11.1 Teva pharmaceutical Industries Ltd. Profile

5.11.2 Teva pharmaceutical Industries Ltd. Main Business

5.11.3 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Products, Services and Solutions

5.11.4 Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.11.5 Teva pharmaceutical Industries Ltd. Recent Developments

5.12 Merc & Co.

5.12.1 Merc & Co. Profile

5.12.2 Merc & Co. Main Business

5.12.3 Merc & Co. Fabry Disease Therapeutic Products, Services and Solutions

5.12.4 Merc & Co. Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.12.5 Merc & Co. Recent Developments

5.13 AbbVie Inc.

5.13.1 AbbVie Inc. Profile

5.13.2 AbbVie Inc. Main Business

5.13.3 AbbVie Inc. Fabry Disease Therapeutic Products, Services and Solutions

5.13.4 AbbVie Inc. Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.13.5 AbbVie Inc. Recent Developments

5.14 Takeda Pharmaceutical Co. Ltd.

5.14.1 Takeda Pharmaceutical Co. Ltd. Profile

5.14.2 Takeda Pharmaceutical Co. Ltd. Main Business

5.14.3 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Products, Services and Solutions

5.14.4 Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.14.5 Takeda Pharmaceutical Co. Ltd. Recent Developments

5.15 Green Cross Corp.

5.15.1 Green Cross Corp. Profile

5.15.2 Green Cross Corp. Main Business

5.15.3 Green Cross Corp. Fabry Disease Therapeutic Products, Services and Solutions

5.15.4 Green Cross Corp. Fabry Disease Therapeutic Revenue (US$ Million) & (2018-2023)

5.15.5 Green Cross Corp. Recent Developments

6 North America

6.1 North America Fabry Disease Therapeutic Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Fabry Disease Therapeutic Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Fabry Disease Therapeutic Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Fabry Disease Therapeutic Market Dynamics

11.1 Fabry Disease Therapeutic Industry Trends

11.2 Fabry Disease Therapeutic Market Drivers

11.3 Fabry Disease Therapeutic Market Challenges

11.4 Fabry Disease Therapeutic Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Novartis Pharmaceuticals

Pfizer Inc

Bristol Myers Squibb Company

GlaxoSmithKline PLC

Amgen Inc

Teva Pharmaceutical Industries Ltd

Merc & Co.

AbbVie

Takeda Pharmaceutical Co Ltd

Green Cross Corp

List of Tables

Table 1. Global Market Fabry Disease Therapeutic Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Fabry Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Fabry Disease Therapeutic Market Size Share by Region (2018-2023)

Table 4. Global Fabry Disease Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Fabry Disease Therapeutic Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Fabry Disease Therapeutic Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Fabry Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Fabry Disease Therapeutic Revenue Market Share by Type (2018-2023)

Table 9. Global Fabry Disease Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Fabry Disease Therapeutic Revenue Market Share by Type (2024-2029)

Table 11. North America Fabry Disease Therapeutic Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Fabry Disease Therapeutic Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Fabry Disease Therapeutic Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Fabry Disease Therapeutic Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Fabry Disease Therapeutic Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Fabry Disease Therapeutic Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Fabry Disease Therapeutic Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Fabry Disease Therapeutic Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Fabry Disease Therapeutic Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Fabry Disease Therapeutic Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Fabry Disease Therapeutic Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Fabry Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Fabry Disease Therapeutic Revenue Market Share by Application (2018-2023)

Table 24. Global Fabry Disease Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Fabry Disease Therapeutic Revenue Market Share by Application (2024-2029)

Table 26. North America Fabry Disease Therapeutic Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Fabry Disease Therapeutic Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Fabry Disease Therapeutic Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Fabry Disease Therapeutic Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Fabry Disease Therapeutic Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Fabry Disease Therapeutic Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Fabry Disease Therapeutic Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Fabry Disease Therapeutic Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Fabry Disease Therapeutic Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Fabry Disease Therapeutic Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Fabry Disease Therapeutic Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Fabry Disease Therapeutic Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fabry Disease Therapeutic as of 2022)

Table 39. Date of Key Players Enter into Fabry Disease Therapeutic Market

Table 40. Global Fabry Disease Therapeutic Key Players Headquarters and Area Served

Table 41. Fabry Disease Therapeutic Product Solution and Service

Table 42. Global Fabry Disease Therapeutic Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Amicus therapeutics Basic Information List

Table 45. Amicus therapeutics Description and Business Overview

Table 46. Amicus therapeutics Fabry Disease Therapeutic Products, Services and Solutions

Table 47. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Amicus therapeutics (2018-2023)

Table 48. Amicus therapeutics Recent Developments

Table 49. Takeda Basic Information List

Table 50. Takeda Description and Business Overview

Table 51. Takeda Fabry Disease Therapeutic Products, Services and Solutions

Table 52. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Takeda (2018-2023)

Table 53. Takeda Recent Developments

Table 54. Genzyme-Sanofi Basic Information List

Table 55. Genzyme-Sanofi Description and Business Overview

Table 56. Genzyme-Sanofi Fabry Disease Therapeutic Products, Services and Solutions

Table 57. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Genzyme-Sanofi (2018-2023)

Table 58. Genzyme-Sanofi Recent Developments

Table 59. Protalix Basic Information List

Table 60. Protalix Description and Business Overview

Table 61. Protalix Fabry Disease Therapeutic Products, Services and Solutions

Table 62. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Protalix (2018-2023)

Table 63. Protalix Recent Developments

Table 64. Sanofi-Aventis LLC Basic Information List

Table 65. Sanofi-Aventis LLC Description and Business Overview

Table 66. Sanofi-Aventis LLC Fabry Disease Therapeutic Products, Services and Solutions

Table 67. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Sanofi-Aventis LLC (2018-2023)

Table 68. Sanofi-Aventis LLC Recent Developments

Table 69. Novartis Pharmaceuticals Basic Information List

Table 70. Novartis Pharmaceuticals Description and Business Overview

Table 71. Novartis Pharmaceuticals Fabry Disease Therapeutic Products, Services and Solutions

Table 72. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Novartis Pharmaceuticals (2018-2023)

Table 73. Novartis Pharmaceuticals Recent Developments

Table 74. Pfizer Basic Information List

Table 75. Pfizer Description and Business Overview

Table 76. Pfizer Fabry Disease Therapeutic Products, Services and Solutions

Table 77. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Pfizer (2018-2023)

Table 78. Pfizer Recent Developments

Table 79. Bristol-Myers Squibb Company Basic Information List

Table 80. Bristol-Myers Squibb Company Description and Business Overview

Table 81. Bristol-Myers Squibb Company Fabry Disease Therapeutic Products, Services and Solutions

Table 82. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Bristol-Myers Squibb Company (2018-2023)

Table 83. Bristol-Myers Squibb Company Recent Developments

Table 84. GlaxoSmithKline plc Basic Information List

Table 85. GlaxoSmithKline plc Description and Business Overview

Table 86. GlaxoSmithKline plc Fabry Disease Therapeutic Products, Services and Solutions

Table 87. Revenue (US$ Million) in Fabry Disease Therapeutic Business of GlaxoSmithKline plc (2018-2023)

Table 88. GlaxoSmithKline plc Recent Developments

Table 89. Amgen Inc. Basic Information List

Table 90. Amgen Inc. Description and Business Overview

Table 91. Amgen Inc. Fabry Disease Therapeutic Products, Services and Solutions

Table 92. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Amgen Inc. (2018-2023)

Table 93. Amgen Inc. Recent Developments

Table 94. Teva pharmaceutical Industries Ltd. Basic Information List

Table 95. Teva pharmaceutical Industries Ltd. Description and Business Overview

Table 96. Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Products, Services and Solutions

Table 97. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Teva pharmaceutical Industries Ltd. (2018-2023)

Table 98. Teva pharmaceutical Industries Ltd. Recent Developments

Table 99. Merc & Co. Basic Information List

Table 100. Merc & Co. Description and Business Overview

Table 101. Merc & Co. Fabry Disease Therapeutic Products, Services and Solutions

Table 102. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Merc & Co. (2018-2023)

Table 103. Merc & Co. Recent Developments

Table 104. AbbVie Inc. Basic Information List

Table 105. AbbVie Inc. Description and Business Overview

Table 106. AbbVie Inc. Fabry Disease Therapeutic Products, Services and Solutions

Table 107. Revenue (US$ Million) in Fabry Disease Therapeutic Business of AbbVie Inc. (2018-2023)

Table 108. AbbVie Inc. Recent Developments

Table 109. Takeda Pharmaceutical Co. Ltd. Basic Information List

Table 110. Takeda Pharmaceutical Co. Ltd. Description and Business Overview

Table 111. Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Products, Services and Solutions

Table 112. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Takeda Pharmaceutical Co. Ltd. (2018-2023)

Table 113. Takeda Pharmaceutical Co. Ltd. Recent Developments

Table 114. Green Cross Corp. Basic Information List

Table 115. Green Cross Corp. Description and Business Overview

Table 116. Green Cross Corp. Fabry Disease Therapeutic Products, Services and Solutions

Table 117. Revenue (US$ Million) in Fabry Disease Therapeutic Business of Green Cross Corp. (2018-2023)

Table 118. Green Cross Corp. Recent Developments

Table 119. North America Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 120. North America Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 121. Europe Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 122. Europe Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 123. Asia-Pacific Fabry Disease Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 124. Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)

Table 125. Asia-Pacific Fabry Disease Therapeutic Market Size by Region (2024-2029) & (US$ Million)

Table 126. Asia-Pacific Fabry Disease Therapeutic Market Share by Region (2018-2023)

Table 127. Asia-Pacific Fabry Disease Therapeutic Market Share by Region (2024-2029)

Table 128. Latin America Fabry Disease Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 129. Latin America Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 130. Latin America Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 131. Middle East & Africa Fabry Disease Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 132. Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)

Table 133. Middle East & Africa Fabry Disease Therapeutic Market Size by Country (2024-2029) & (US$ Million)

Table 134. Fabry Disease Therapeutic Market Trends

Table 135. Fabry Disease Therapeutic Market Drivers

Table 136. Fabry Disease Therapeutic Market Challenges

Table 137. Fabry Disease Therapeutic Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Fabry Disease Therapeutic Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Fabry Disease Therapeutic Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Fabry Disease Therapeutic Market Share by Regions: 2022 VS 2029

Figure 4. Global Fabry Disease Therapeutic Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Fabry Disease Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Fabry Disease Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Fabry Disease Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Fabry Disease Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Fabry Disease Therapeutic Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Enzyme Replacement Therapy

Figure 11. Global Enzyme Replacement Therapy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Alternative therapies

Figure 13. Global Alternative therapies Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global Fabry Disease Therapeutic Market Size Share by Type: 2022 & 2029

Figure 15. North America Fabry Disease Therapeutic Revenue Market Share by Type (2018-2029)

Figure 16. Europe Fabry Disease Therapeutic Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific Fabry Disease Therapeutic Revenue Market Share by Type (2018-2029)

Figure 18. Latin America Fabry Disease Therapeutic Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa Fabry Disease Therapeutic Revenue Market Share by Type (2018-2029)

Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Global Fabry Disease Therapeutic Market Size Share by Application: 2022 & 2029

Figure 24. North America Fabry Disease Therapeutic Revenue Market Share by Application (2018-2029)

Figure 25. Europe Fabry Disease Therapeutic Revenue Market Share by Application (2018-2029)

Figure 26. Asia-Pacific Fabry Disease Therapeutic Revenue Market Share by Application (2018-2029)

Figure 27. Latin America Fabry Disease Therapeutic Revenue Market Share by Application (2018-2029)

Figure 28. Middle East and Africa Fabry Disease Therapeutic Revenue Market Share by Application (2018-2029)

Figure 29. Fabry Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 30. Global Top 5 and Top 10 Players Fabry Disease Therapeutic Market Share in 2022

Figure 31. North America Fabry Disease Therapeutic Market Share by Country (2018-2029)

Figure 32. U.S. Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 33. Canada Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 34. Germany Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 35. France Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 36. U.K. Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 37. Italy Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 38. Russia Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 39. Nordic Countries Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 40. Asia-Pacific Fabry Disease Therapeutic Market Share by Region (2018-2029)

Figure 41. China Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 42. Japan Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 43. South Korea Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 44. Southeast Asia Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 45. India Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 46. Australia Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 47. Latin America Fabry Disease Therapeutic Market Share by Country (2018-2029)

Figure 48. Mexico Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 49. Brazil Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 50. Middle East & Africa Fabry Disease Therapeutic Market Share by Country (2018-2029)

Figure 51. Turkey Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 53. UAE Fabry Disease Therapeutic Market Size (2018-2029) & (US$ Million)

Figure 54. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions